NCT06727019View on ClinicalTrials.gov

Daily Low-level Red Light and 0.01% Low-dose Atropine for Myopia Prevention

NACompletedINTERVENTIONAL
Enrollment

138

Participants

Timeline

Start Date

April 10, 2023

Primary Completion Date

September 15, 2023

Study Completion Date

September 15, 2023

Conditions
Myopia
Interventions
DEVICE

low-level red-light

650-nm low-level red-light

DRUG

Atropine (0.01%)

Atropine eye drops at concentration of 0.01%

Trial Locations (1)

Unknown

Beijing Tongren Hospital, Beijing

All Listed Sponsors
lead

Beijing Tongren Hospital

OTHER